Will EQPT file its Q1 2026 10-Q on time with no material weakness disclosure?
Current Prediction
Why This Question Matters
First 10-Q filing under public-company timeline is the cleanest test of disclosure-control maturity flagged by Prospectus Probe (no auditor ICFR attestation in first 10-K). A clean Q1 10-Q with no material weakness disclosure validates the GOVERNANCE_ALIGNMENT=MIXED assessment leaning constructive. A late filing or material weakness disclosure would push GOVERNANCE_ALIGNMENT toward UNCONSTRUCTIVE and ASSUMPTION_FRAGILITY higher.
Prediction Distribution
Individual Predictions(9 runs)
Base rate clean+on-time first 10-Q: ~78-85%. EQPT filed FY 2025 10-K on time, KPMG signed off, no material litigation. Issuer-specific risks: first-year ICFR self-assessment without auditor attestation + KPMG critical audit matter on sale-leaseback. Risks discount baseline by ~5-10pp. ~78%.
Mgmt narrative incentive is acute (capital structure depends on continued debt-market access). Public-company finance team in place. CFO open-market purchase signals confidence. Sale-leaseback restatement is separate event (3-7% probability), not first-10-Q-specific. Per-10-Q late-filing alone ~5%, material weakness ~3%. Combined NO probability ~20%. ~80%.
Construction-equipment SaaS-style accounting complexity (sale-leaseback, OWN Program, finance leases) elevates first-10-Q risk above simple-business issuers. First-year-public companies have ~12-18% rate of late filings or material restatements within first 12 months — Q1 is biggest single-event exposure within that. Lean modestly below baseline. ~76%.
78-85% baseline cleanness for newly public companies; EQPT is in baseline range with mild downside from accounting complexity (sale-leaseback critical audit matter). Mgmt incentive strong but ICFR transition relief is a residual risk. ~77%.
Q1 deadline is May 14, 2026 (~3 weeks). EQPT 10-K filing pattern shows discipline. KPMG critical audit matter is disclosed risk; restatement is a separate market. Probability of clean filing benefits from short window for material weakness emergence at Q1 vs annual scrutiny. ~81%.
Q1 10-Q is the first stress test of public-company controls. Newly-public issuers tend to surface refinements and segment reclassifications in first quarterly disclosures. Material weakness specifically (per resolution criteria) is rarer than generic refinement. ~75%.
Newly public, on-time 10-K, mgmt narrative incentive. Issuer-specific accounting complexity. Baseline 78-85% adjusted modestly down. ~78%.
Mgmt incentive + KPMG continuity + CFO buy. Material weakness is rare event in first 10-Q without prior signals. ~80%.
Per-10-Q late filing ~5%, material weakness ~3%, sale-leaseback escalation ~3-5% specific to Q1. Combined ~21%. NO ~21%, YES ~79%. ~79%.
Resolution Criteria
Resolves YES if EQPT files its Q1 2026 10-Q with the SEC by May 18, 2026 (3-business-day grace period over the standard 40-day deadline applicable to non-large accelerated filers) AND the filing contains no disclosure of material weakness in internal control over financial reporting AND no NT 10-Q (Form 12b-25) extension filing. Resolves NO if any of the following occur: (a) Form 12b-25 extension filed; (b) 10-Q filed after May 18, 2026; (c) management discloses material weakness in ICFR per Item 4 (Controls and Procedures) or KPMG identifies material weakness in any review-level communication disclosed in the filing.
Resolution Source
SEC EDGAR (10-Q filing); Item 4 Controls and Procedures disclosure
Source Trigger
First post-IPO 10-Q (Q1 2026) is the first quarterly disclosure under public-company timelines. Test of disclosure controls and segment reclassification or accounting refinement.
Full multi-lens equity analysis